Catalysts for Celgene Corp
6 tracked
Feb 27, 2026
approval
REBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
luspatercept
→
May 16, 2024
approval
REBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
luspatercept
→
Aug 28, 2023
approval
REBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
luspatercept
→
Jul 8, 2022
approval
REBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
luspatercept
→
Apr 3, 2020
approval
REBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
luspatercept
→
Nov 8, 2019
approval
REBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
luspatercept
→